- Home
- ARTW vs SNGX Comparison
ARTW vs SNGX Comparison
Compare ARTW & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- SNGX
- Stock Information
- Founded
- ARTW 1956
- SNGX 1987
- Country
- ARTW United States
- SNGX United States
- Employees
- ARTW N/A
- SNGX N/A
- Industry
- ARTW Industrial Machinery/Components
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- SNGX Health Care
- Exchange
- ARTW Nasdaq
- SNGX Nasdaq
- Market Cap
- ARTW 12.5M
- SNGX 13.8M
- IPO Year
- ARTW N/A
- SNGX 1987
- Fundamental
- Price
- ARTW $2.50
- SNGX $1.56
- Analyst Decision
- ARTW
- SNGX Strong Buy
- Analyst Count
- ARTW 0
- SNGX 1
- Target Price
- ARTW N/A
- SNGX $6.00
- AVG Volume (30 Days)
- ARTW 60.0K
- SNGX 2.1M
- Earning Date
- ARTW 10-07-2025
- SNGX 11-10-2025
- Dividend Yield
- ARTW N/A
- SNGX N/A
- EPS Growth
- ARTW N/A
- SNGX N/A
- EPS
- ARTW 0.49
- SNGX N/A
- Revenue
- ARTW $24,079,949.00
- SNGX N/A
- Revenue This Year
- ARTW N/A
- SNGX N/A
- Revenue Next Year
- ARTW N/A
- SNGX N/A
- P/E Ratio
- ARTW $6.61
- SNGX N/A
- Revenue Growth
- ARTW N/A
- SNGX N/A
- 52 Week Low
- ARTW $1.43
- SNGX $1.09
- 52 Week High
- ARTW $4.71
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- ARTW 42.61
- SNGX 41.04
- Support Level
- ARTW $2.30
- SNGX $1.54
- Resistance Level
- ARTW $2.67
- SNGX $1.76
- Average True Range (ATR)
- ARTW 0.26
- SNGX 0.11
- MACD
- ARTW -0.02
- SNGX 0.04
- Stochastic Oscillator
- ARTW 22.02
- SNGX 10.87
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).